Cynthia Timmers to Lung Neoplasms
This is a "connection" page, showing publications Cynthia Timmers has written about Lung Neoplasms.
Connection Strength
0.413
-
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer. Lung Cancer. 2019 08; 134:167-173.
Score: 0.086
-
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations. Mol Cancer Ther. 2018 01; 17(1):17-25.
Score: 0.077
-
A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma. Cancer Res. 2017 01 01; 77(1):153-163.
Score: 0.072
-
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis. J Thorac Oncol. 2015 Oct; 10(10):1430-6.
Score: 0.067
-
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing. J Clin Oncol. 2015 Jun 10; 33(17):1966-73.
Score: 0.065
-
Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 2004 Apr 29; 23(20):3521-9.
Score: 0.030
-
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency. PLoS One. 2015; 10(11):e0143092.
Score: 0.017